BPC-157 vs Pentadeca Arginate
The same fifteen-amino-acid healing pitch twice: one molecule with a deep rodent literature behind it, and one with a near-empty file of its own.
BPC-157
Almost entirely animal data; no validated human dose and no controlled efficacy trials.
Full BPC-157 evidence reviewPentadeca Arginate
PDA
Marketed as a more stable upgrade on BPC-157, but it has almost no research of its own — the evidence base is borrowed and preclinical.
Full Pentadeca Arginate evidence reviewSide by side
| BPC-157 | Pentadeca Arginate | |
|---|---|---|
| Marketed for | Healing, recovery, gut health | Healing, recovery (a 'stable BPC-157') |
| Evidence grade | Preclinical / minimal | Preclinical / minimal |
| Family | Repair / structural | Repair / structural |
| Regulatory status | Not FDA-approved | Not FDA-approved |
| How it's obtained | Research-only | Research-only |
| Key human source | Pharmaceutics review, 2026 | Sikiric, Inflammopharmacology 2024 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
BPC-157 at least owns its evidence: a consistent preclinical resume across tendon, ligament, muscle, bone and gastrointestinal models, though there are no published randomized human trials for any indication, no established dosing and no human pharmacokinetics. Pentadeca arginate is marketed as a more stable, more soluble arginate-salt upgrade, but there is essentially no independent published research on PDA specifically; nearly every benefit claimed for it is borrowed from the BPC-157 literature on the untested assumption that the salt form behaves identically. Both are unapproved and sold research-use-only, so this is a choice between a thin preclinical base and a borrowed one, not between two treatments.
BPC-157 fits if
Someone who wants to read the actual literature behind this class, since BPC-157 is the molecule the studies were run on.
Pentadeca Arginate fits if
Hard to name one on evidence grounds; PDA's only distinct claim is formulation stability, which says nothing about whether it does anything in a person.
Where to get it
Where to get peptide therapy
Clinician-led telehealth services that prescribe compounded peptides. The specific peptides offered vary by provider — confirm BPC-157 availability before ordering.
